Aura Biosciences (AURA) Other Operating Expenses (2021 - 2022)

Aura Biosciences (AURA) posted Other Operating Expenses of -$313000.0 for Q3 2022, down 6160.0% on a QoQ basis from -$5000.0 in Q1 2022.

Aura Biosciences (AURA) Other Operating Expenses (2021 - 2022) Analysis & Trends

Aura Biosciences' Other Operating Expenses history runs 2 years deep, the most recent figure standing at -$313000.0 for Q3 2022.

Quarterly Other Operating Expenses changed N/A year-over-year to -$313000.0 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was -$313000.0 (down 6160.0% YoY) and the FY2023 annual result came in at $208000.0, up 165.41% from the prior year.
Other Operating Expenses was -$313000.0 for Q3 2022 at Aura Biosciences, down from -$5000.0 in the prior quarter.
Across five years, Other Operating Expenses topped out at -$3000.0 in Q1 2021 and bottomed at -$313000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Aura Biosciences	485.62 Mn	400.83 Mn	-

Download Data